Similar articles for PMID: 23907459

Year	Number of Results
2010	1
2011	3
2012	10
2013	20
2014	26
2015	29
2016	17
2017	20
2018	15
2019	14
2020	10
2021	15
2022	17
2023	7
2024	0

1

KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.

Huang L, Wang HY, Li JD, Wang JH, Zhou Y, Luo RZ, Yun JP, Zhang Y, Jia WH, Zheng M. Huang L, et al. Cell Death Dis. 2013 Aug 1;4(8):e745. doi: 10.1038/cddis.2013.256. Cell Death Dis. 2013. PMID: 23907459 Free PMC article.

2

MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.

Lin J, Zhang L, Huang H, Huang Y, Huang L, Wang J, Huang S, He L, Zhou Y, Jia W, Yun J, Luo R, Zheng M. Lin J, et al. Oncotarget. 2015 Sep 15;6(27):23793-806. doi: 10.18632/oncotarget.4363. Oncotarget. 2015. PMID: 26204489 Free PMC article.

3

The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.

Jiang L, Liu R, Wang Y, Li C, Xi Q, Zhong J, Liu J, Yang S, Wang J, Huang M, Tang C, Fang Z. Jiang L, et al. J Mol Histol. 2015 Jun;46(3):291-302. doi: 10.1007/s10735-015-9622-7. Epub 2015 May 17. J Mol Histol. 2015. PMID: 25981880

4

Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.

Zhang R, Shi H, Ren F, Liu H, Zhang M, Deng Y, Li X. Zhang R, et al. Oncol Rep. 2015 Mar;33(3):1235-42. doi: 10.3892/or.2015.3723. Epub 2015 Jan 15. Oncol Rep. 2015. PMID: 25592872

5

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.

Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A. Tassi RA, et al. J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y. J Exp Clin Cancer Res. 2017. PMID: 28482906 Free PMC article.

6

CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.

Li T, Xue H, Guo Y, Guo K. Li T, et al. Oncol Rep. 2014 Apr;31(4):1825-31. doi: 10.3892/or.2014.3045. Epub 2014 Feb 20. Oncol Rep. 2014. PMID: 24573179

7

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.

Barger CJ, Zhang W, Hillman J, Stablewski AB, Higgins MJ, Vanderhyden BC, Odunsi K, Karpf AR. Barger CJ, et al. Oncotarget. 2015 Sep 29;6(29):27613-27. doi: 10.18632/oncotarget.4546. Oncotarget. 2015. PMID: 26243836 Free PMC article.

8

Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.

Zeng S, Liu S, Feng J, Gao J, Xue F. Zeng S, et al. Cancer Biomark. 2019;24(4):421-428. doi: 10.3233/CBM-182160. Cancer Biomark. 2019. PMID: 30909184

9

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.

Peng DX, Luo M, Qiu LW, He YL, Wang XF. Peng DX, et al. Oncol Rep. 2012 Apr;27(4):1238-44. doi: 10.3892/or.2012.1625. Epub 2012 Jan 11. Oncol Rep. 2012. PMID: 22246341 Free PMC article.

10

Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.

Dong L, Che H, Li M, Li X. Dong L, et al. Med Sci Monit. 2016 Sep 13;22:3248-56. doi: 10.12659/msm.899980. Med Sci Monit. 2016. PMID: 27623016 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

181 results

Results by year